trimetazidine has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Day, SM | 1 |
| Coats, CJ; Elliott, PM; Frenneaux, MP; Hyland, R; McKenna, WJ; Moss, L; Omar, R; Pantazis, AA; Pavlou, M; Protonotarios, A; Rantell, K; Tome, M; Watkinson, OT | 1 |
| van der Velden, J; van Driel, B | 1 |
| Coats, CJ; Elliott, PM; Frenneaux, MP | 1 |
| D'hahan, N; Dassouli, A; Morel, JE; Taouil, K | 1 |
| D'hahan, N | 1 |
1 review(s) available for trimetazidine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Trimetazidine: potential mechanisms of action in hypertrophic cardiomyopathy.
Topics: Animals; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Humans; Trimetazidine; Vasodilator Agents | 1999 |
1 trial(s) available for trimetazidine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.
Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Hypertrophic; Exercise Tolerance; Fatty Acids; Female; Heart Failure; Humans; Male; Middle Aged; Myocardium; Open Bite; Oxygen Consumption; Quality of Life; Trimetazidine; United Kingdom; Vasodilator Agents | 2019 |
4 other study(ies) available for trimetazidine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Nonobstructive Hypertrophic Cardiomyopathy-The High-Hanging Fruit.
Topics: Cardiomyopathy, Hypertrophic; Exercise; Exercise Tolerance; Humans; Trimetazidine | 2019 |
Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?
Topics: Cardiomyopathy, Hypertrophic; Exercise Tolerance; Humans; Phenotype; Trimetazidine | 2019 |
Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?-Reply.
Topics: Cardiomyopathy, Hypertrophic; Exercise Tolerance; Humans; Mutation; Trimetazidine | 2019 |
Long-term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6.
Topics: Animals; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cricetinae; Heart Ventricles; In Vitro Techniques; Long-Term Care; Mesocricetus; Myocardium; Survival Rate; Trimetazidine; Vasodilator Agents; Verapamil | 1997 |